IL17A and metabolic dysfunction-associated steatohepatitis: Transfer of HF/HCD-treated mice with WT hepatic γδ T cells, but not with IL-17A-/- hepatic γδ T cells, exacerbated NASH in Tcrd-/- mice, suggesting that hepatic γδ T cells may contribute to NASH progression (109).